AstraZeneca PLC (NASDAQ:AZN) Q1 2025 Earnings Call Transcript April 29, 2025
AstraZeneca PLC beats earnings expectations. Reported EPS is $1.3, expectations were $1.1.
Andy Barnett – Head of IR:
Pascal Soriot – Executive Director and CEO:
Aradhana Sarin – Executive Director and CFO:
Dave Fredrickson – EVP, Oncology Business Unit:
Susan Galbraith – EVP, Oncology R&D:
Q&A Session
Q1 2025MSN NewsNASDAQ:AZNEarnings Call Transcript
